Vaccination route matters for mucosal tumors

Science Translational Medicine

Volumn 5, Issue 172, 2013, Pages

  Nardelli Haefliger, Denise ^a   Dudda, Jan C ^b   Romero, Pedro ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTEGRIN; CANCER VACCINE;

ANTIGEN PRESENTATION; CANCER IMMUNOTHERAPY; CELL HOMING; CELLULAR DISTRIBUTION; DENDRITIC CELL; EFFECTOR CELL; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; LYMPHOCYTE ACTIVATION; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; TUMOR LOCALIZATION;

ANIMALS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOTAXIS, LEUKOCYTE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNITY, MUCOSAL; LUNG NEOPLASMS; NASAL MUCOSA; PAPILLOMAVIRUS VACCINES;

EID: 84874065038     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005638     Document Type: Short Survey

References (6)

1. + T cells is crucial to inhibit the growth of mucosal tumors. Sci. Transl. Med. 5, 172ra20 (2013).
2. M. Richter, S. J. Ray, T. J. Chapman, S. J. Austin, J. Rebhahn, T. R. Mosmann, H. Gardner, V. Kotelianski, A. R. deFougerolles, D. J. Topham, Collagen distribution and expression of collagen-binding alpha1beta1 (VLA-1) and alpha-2beta1 (VLA-2) integrins on CD4 and CD8 T cells during influenza infection. J. Immunol. 178, 4506-4516 (2007).
3. L. Decrausaz, S. Domingos-Pereira, M. Duc, M. Bobst, P. Romero, J. T. Schiller, P. Jichlinski, D. Nardelli-Haefliger, Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus- associated genital tumors. Int. J. Cancer 129, 762-772 (2011).
4. S. Domingos-Pereira, L. Decrausaz, L. Derré, M. Bobst, P. Romero, J. T. Schiller, P. Jichlinski, D. Nardelli-Haefliger, Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice. Mucosal Immunol. 10.1038/mi.2012.83 (2012).
5. H. Shin, A. Iwasaki, A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 491, 463-467 (2012).
6. J. M. Langley, F. Aoki, B. J. Ward, A. McGeer, J. B. Angel, G. Stiver, I. Gorfinkel, D. Shu, L. White, B. Lasko, P. Dzon-gowski, K. Papp, M. Alexander, G. Boivin, L. Fries, A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness. Vaccine 29, 1921-1928 (2011).